Kathryn Harris

Kathryn Harris serves as the Senior Director, Compliance Business Partner at Emergent BioSolutions. In this role, she develops Emergent’s global compliance program while supporting product teams, including Narcan and Medical Counter Measures. Prior to joining Emergent, Kathryn was the Compliance Business partner for Patient Services, Market Access, and Strategic Accounts at Alexion, the rare disease business unit of AstraZeneca. Prior to her business partnering roles, Kathryn managed global investigations for Alexion and later AstraZeneca. Before going in house, Kathryn was a litigator at Ropes & Gray LLP where she served as outside counsel in high stakes internal and government investigations.